Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Adenocarcinoma

Explore clinical trials studying Metastatic Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

81 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Adenocarcinoma trial results

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

NCT04616534

Conditions
Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +40 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

NCT03816163

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • St. Joseph Heritage Medical Group Fullerton, California, United States
  • TOI Clinical research Whittier, California, United States
  • Midstate Medical Center Meriden, Connecticut, United States
  • Lynn Cancer Institute Boca Raton, Florida, United States
View all 136 locations
View Trial Details
Active, not recruiting

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

NCT04233866

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 760 locations
View Trial Details
Active, not recruiting

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

NCT03257761

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05642962

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

NCT05249101

Conditions
Metastatic Pancreatic Adenocarcinoma
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Hoag Medical Group Newport Beach, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • UCLA Hematology/Oncology, Gastrointestinal Oncology Santa Monica, California, United States
View all 16 locations
View Trial Details

Related conditions